Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-26

Clinical Trial Update: Low-dose KETamine as an Adjunct to MOrphine for Acute Pain in the ED [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating low-dose ketamine as an adjunct to morphine for acute pain in the emergency department; the study is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: University of Aarhus | Conditions: Acute Pain, Opioid Use | Phase 4 | Status: TERMINATED